Evaluation of Patients with Heart Failure to Determine Eligibility for Treatment with Sacubitril/Valsartan: Insights from a Veterans Administration Healthcare System-Reference-Cited by-同舟云学术

Evaluation of Patients with Heart Failure to Determine Eligibility for Treatment with Sacubitril/Valsartan: Insights from a Veterans Administration Healthcare System

Published:2019-10-10 Issue:11 Volume:39 Page:1053-1059
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Han Jamie¹,Chung Francisco¹,Nguyen Quyen L.¹,Mody Freny Vaghaiwalla¹²³,Jackevicius Cynthia A.¹⁴⁵⁶^ORCID

Affiliation:

1. Veterans Affairs Greater Los Angeles Healthcare System Los Angeles California

2. Division of Cardiology University of California, Los Angeles Los Angeles California

3. David Geffen School of Medicine University of California, Los Angeles Los Angeles California

4. Department of Pharmacy Practice and Administration Western University of Health Sciences Pomona California

5. Institute for Clinical Evaluative Sciences University of Toronto Toronto Ontario Canada

6. Institute of Health Policy, Management and Evaluation University of Toronto Toronto Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2328

Reference21 articles.

1. The Impact of Worsening Heart Failure in the United States

2. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines;Yancy CW;Circulation,2013

3. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

4. Entresto[package insert].East Hanover NJ:Novartis;2015.

5. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sacubitril/Valsartan Initiation Among Veterans Who Are Renin‐Angiotensin‐Aldosterone System Inhibitor Naïve With Heart Failure and Reduced Ejection Fraction;Journal of the American Heart Association;2021-10-19

2. Disease-modifier Drugs in Patients with Advanced Heart Failure;Heart Failure Clinics;2021-10

3. Prior Authorization, Copayments, and Utilization of Sacubitril/Valsartan in Medicare and Commercial Plans in Patients With Heart Failure With Reduced Ejection Fraction;Circulation: Cardiovascular Quality and Outcomes;2021-09

4. National Trends in the Use of Sacubitril/Valsartan;Journal of Cardiac Failure;2021-08

5. Implementing a PARADIGM Shift;Journal of Cardiac Failure;2021-08